secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definitive Healthcare Corp. (DH)
CIK:        0001861795
Form:       8-K
Filed at:   2023-02-23T23:59:59+00:00
Accession:  0000950170-23-004128
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Definitive Healthcare Q4 revenue up 31% to $60.6M; FY23 guidance implies 14% growth
--------------------------------------------------------------------------------

- Q4 revenue $60.6M (+31% YoY); GAAP net income $6.7M vs loss $14.8M in Q4 2021.
- Full year 2022 revenue $222.7M (+34%); GAAP net loss $22.3M vs $61.3M loss prior year.
- Adjusted EBITDA Q4 $17.0M (28% margin); full year $63.7M (29% margin).
- Q1 2023 revenue guidance $56.5-58.5M (median +15% YoY); FY2023 revenue $249-255M (+14% at midpoint).
- Executive Chairman Jason Krantz base salary reduced to $1,000/week, granted 18,465 RSUs, no 2023 bonus; CEO/CFO/Chairman received cash bonuses for 2022 despite missing targets.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861795/000095017023004128/0000950170-23-004128-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861795/000095017023004128/dh-20230216.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-004128

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer